Improving Health-Related Quality of Life in Gastro-Oesophageal Reflux Disease

被引:0
|
作者
Michael J. Shaw
Joseph A. Crawley
机构
[1] Park Nicollet Medical Foundation Health Research Center,
[2] Health Economics and Outcomes Research,undefined
[3] AstraZeneca LP,undefined
来源
Drugs | 2003年 / 63卷
关键词
Omeprazole; Proton Pump Inhibitor; Ranitidine; Esomeprazole; Erosive Oesophagitis;
D O I
暂无
中图分类号
学科分类号
摘要
Gastro-oesophageal reflux disease (GORD) is a common, chronic disorder that can progress to erosive or ulcerative oesophagitis and other complications. Uncomplicated GORD can be defined using criteria that combine symptom assessment and the impact of symptoms on well being or quality of life. The extent of impairment of health-related quality of life (HRQL) in GORD patients has been evaluated using generic HRQL questionnaires, GORD-specific quality of life questionnaires or a combination of the two types of instruments. The impact of GORD on HRQL in affected individuals is proportional to the frequency and severity of heartburn, and is greater than that associated with many other chronic diseases. In the treatment of GORD, the goal should be complete symptom resolution as this has been shown to be associated with a clinically significant improvement in HRQL. Both drug treatment and surgical intervention have been successful in improving HRQL of patients with GORD when complete symptom resolution can be attained
引用
收藏
页码:2307 / 2316
页数:9
相关论文
共 50 条
  • [1] Improving health-related quality of life in gastro-oesophageal reflux disease
    Shaw, MJ
    Crawley, JA
    [J]. DRUGS, 2003, 63 (21) : 2307 - 2316
  • [2] Health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease
    Chassany, O.
    Holtmann, G.
    Malagelada, J.
    Gebauer, U.
    Doerfler, H.
    Devault, K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (11) : 1053 - 1070
  • [3] The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life - A literature review
    Prasad, M
    Rentz, AM
    Revicki, DA
    [J]. PHARMACOECONOMICS, 2003, 21 (11) : 769 - 790
  • [4] Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life
    Tack, J.
    Becher, A.
    Mulligan, C.
    Johnson, D. A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (11) : 1257 - 1266
  • [5] Quality of life in gastro-oesophageal reflux disease
    Kamolz, T
    Velanovich, V
    [J]. DIGESTIVE AND LIVER DISEASE, 2001, 33 (09) : 737 - 739
  • [6] Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease
    Revicki, DA
    Crawley, JA
    Zodet, MW
    Levine, DS
    Joelsson, BO
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (12) : 1621 - 1630
  • [7] International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease
    Holtmann, G.
    Chassany, O.
    Devault, K. R.
    Schmitt, H.
    Gebauer, U.
    Doerfler, H.
    Malagelada, J. R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (06) : 615 - 625
  • [8] Development of a health-related quality of life questionnaire for gastro-oesophageal reflux disease patients: A validation study
    Colwell, HH
    Mathias, SD
    Pasta, DJ
    Henning, JM
    Hunt, RH
    [J]. QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 73 - 73
  • [9] Quality of life and gastro-oesophageal reflux disease management
    Zarb-Adami, Maurice
    Serracino-Inglott, Anthony
    Azzopardi, Lilian M.
    Foden, Melanie
    [J]. PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 131 - 131
  • [10] Quality of life assessment in gastro-oesophageal reflux disease
    Irvine, EJ
    [J]. GUT, 2004, 53 : 35 - 39